Asthma has no cure, yet most flares are controllable
In 2023 it affected an estimated 363 million people and caused about 442,000 deaths, mostly in lower-income countries. Airways tighten and mucus thickens when triggers hit—an ancient Greek word for panting that Egypt already recognized.
Asthma is a long-term inflammatory airway disease with variable, recurring symptoms and reduced lung function: wheezing, cough, chest tightness, and shortness of breath. Attacks can follow inhaled allergens, pollen, dust, or other particles as bronchioles constrict and mucus limits oxygen flow to alveoli. Episodes may come a few times a day or a few times a week; many people worsen at night or with exercise. Genes and environment share blame—air pollution and allergens are leading environmental factors, and drugs such as aspirin or beta blockers can trigger flares. Diagnosis leans on symptom patterns, treatment response, and spirometry.
There is no known cure, but control is realistic. Avoiding triggers and using inhaled corticosteroids suppress inflammation; long-acting beta agonists or antileukotrienes can be added when steroids alone fail. Rapid worsening usually meets short-acting beta2 agonists such as salbutamol, oral steroids, and oxygen; severe cases may need intravenous steroids and hospital care. Severity is judged by how much medicine is required for control; control itself tracks symptom burden and future risk, independent of that medication ladder. Clinicians also speak of phenotypes and endotypes—especially T2-high (eosinophils, raised FeNO, allergy) versus less-mapped T2-low patterns.
Asthma is often treated as a syndrome rather than one disease, historically split into extrinsic (allergic) and intrinsic forms. It overlaps with COPD in restricted airflow, yet asthma’s obstruction fluctuates while COPD’s tends to be chronic and progressive. Comorbidities—allergic rhinitis, obesity, reflux, sleep apnea, anxiety, depression, and others—are common in severe disease and can worsen outcomes. Recognized since ancient Egypt and named from Greek âsthma (“panting”), asthma often begins in childhood. The 2023 global toll—hundreds of millions living with it, hundreds of thousands dying—falls hardest where care access is thinnest.
Source: Asthma
